Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJP-0035 for Corneal Epithelial Wound Healing
NCT02104388Phase 2Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Apr 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fonadelpar in Corneal epithelial defect, superficial punctate keratitis (SPK), corneal erosion, sponsored by Senju Pharmaceutical Co., Ltd.. Started Apr 2014; status: completed.
02
Drugs
fonadelpar
03
Conditions
Corneal epithelial defectsuperficial punctate keratitis (SPK)corneal erosion
Beyond the preview
Go deeper on NCT02104388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104388.